Clinical trial
Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in…
NCT00151918 · Shire, Industry · Completed
Key facts
| NCT number | NCT00151918 |
|---|---|
| Title | Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease |
| Official title | A Multi-Centre, Open Label, Randomized, Parallel Group Pilot Study to Assess the Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic |
| Intervention type | Drug |
| Interventions | Lanthanum carbonate |
| Enrollment | 48 |
| Start date | Jan 7, 2005 |
| Primary completion | Aug 22, 2005 |
| Completion | Aug 22, 2005 |
| First posted | Sep 9, 2005 |
| Last update posted | Jul 6, 2021 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: